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ABSTRACT 
Positron emission tomography (PET) is a non-invasive imaging modality, which is clinically widely used both for 
diagnosis and accessing therapy response in oncology, cardiology and neurology. 
Fusing PET and CT images in a single dataset would be useful for physicians who could read the functional and the 
anatomical aspects of a disease in a single shot. 
The use of fusion software has been replaced in the last few years by integrated PET/CT systems, which combine a 
PET and a CT scanner in the same gantry. CT images have the double function to correct PET images for attenuation 
and can fuse with PET for a better visualization and localization of lesions. The use of CT for attenuation correction 
yields several advantages in terms of accuracy and patient comfort, but can also introduce several artefacts on PET-
corrected images. 
PET/CT image artefacts are due primarily to metallic implants, respiratory motion, use of contrast media and image 
truncation. This paper reviews different types artefacts and their correction methods. 
PET/CT improves image quality and image accuracy. However, to avoid possible pitfalls the simultaneous display 
of both Computed Tomography Attenuation Corrected (CTAC) and non corrected PET images, side by side with CT 
images is strongly recommended. © 2006 Biomedical Imaging and Intervention Journal. All rights reserved. 
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INTRODUCTION 
Positron  emission  tomography  (PET)  is  a  non-
invasive  imaging  modality,  which  is  clinically  widely 
used both for diagnosis and accessing therapy response 
in oncology, cardiology and neurology [1-3]. 
Because of its very high sensitivity it is an excellent 
tool to recognise malignant nodules and lesions earlier 
than  their  anatomical  compromising.  The  lack  of 
anatomic  information  in  PET  images  can  be 
compensated  by  other  complementary  imaging 
techniques such as CT or MRI read side by side. Several 
methods have been developed to register and fuse PET 
and  CT  data  acquired  on  separate  systems  [4-5].  The 
major  problems  related  with  image  fusion  are  the 
different formats of images of the two datasets and the 
need  to  use  external  markers,  visible  with  both 
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modalities,  to  be  sure  to  have  a  good  match  among 
corresponding images. 
The ideal condition for image fusion is to have the 
two datasets acquired closely sequentially on the same 
system [6-7]. 
It has been well established that the fusion of PET 
and  CT  provides  information  exceeding  the  sum 
derivable from the two modalities treated separately [8-
17].  
The advantages of PET/CT over PET are: 
1.  Faster  and  less  noisy  attenuation  correction 
maps 
2.  Better diagnostic accuracy especially in disease 
staging  
3.  Better ability to identify and localise lesions 
4.  Shorter  transmission  acquisition  time  with  a 
consequent  better  comfort  for  the  patient  and 
less probability of patient motion. 
This paper describes all different artefacts that can 
be caused by the use of a combined PET/CT system and 
that  can  affect  the  accuracy  of  PET-corrected  images 
[18-19]. 
PET/CT SCANNER DESIGN 
A  PET/CT  scanner  combines  PET  and  CT 
technology in the same gantry. The patient, lying on the 
table, undergoes CT and the PET scan sequentially. 
The first PET/CT system, developed and installed at 
the  University  of  Pittsburg,  was  based  on  the 
combination of a spiral CT scan (Somatom AR.SP) with 
a rotating partial ring PET scanner (ECAT ART) [20]. 
In all modern commercial systems [21-24] the CT is 
on the front and the PET is on the back: the patient first 
undergoes the CT scan and then the PET scan (Figure 1). 
No  limitations  exist  on  the  type  of  systems 
employed: the CT can be single or multislice, working in 
either axial or helical mode while the PET system can 
use  a  different  crystal  material  (BGO,  LSO,  LYSO, 
GSO). Some PET systems can acquire in either 2D or 3D 
mode whereas others can only acquire in 3D mode. 
ACQUISITION PROTOCOLS 
A PET/CT acquisition protocol has three steps: a) 
SCOUT  acquisition  for  axial  Field  of  View  (FOV) 
definition, b) CT acquisition, and c) PET acquisition. 
Because  CT  is  used  mostly  to  fuse  anatomical 
information  to  functional  PET  images  and  to  correct 
attenuation, low-dose CT protocols can be adopted as a 
compromise  between  acceptable  image  quality  and 
absorbed  dose  to  the  patient.  This  kind  of  CT  images 
cannot be used on their own for diagnosis. 
The common CT protocol uses 100-140 kV and 60-
100  mA:  the  nuclear  medicine  technologist  should 
modify  these  values  according  to  the  weight  of  the 
patient [25]. Additional conservative parameters should 
be selected for paediatric studies. 
The duration of PET scan is about 3-5 minutes/bed 
position  and  depends  on  different  factors  such  as  the 
acquisition mode (2D or 3D), the injected dose and the 
time between the administration of the activity and the 
acquisition start time. Because PET image matrix size is 
128x128  and  CT  is  512x512,  CT  data  need  to  be 
 
Figure 1  These images show the layouts of the three commercial family systems available on the market: a) 
Siemens/CTI Biograph, b) GE Healthcare Discovery, c) Philips Gemini. 
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rebinned to perform image registration and attenuation 
correction. 
ATTENUATION CORRECTION 
In conventional PET, attenuation correction is done 
using  transmission  scans  acquired  with  external 
radioactive  sources:  most  systems  use 
68Ge  rods.  The 
transmission  acquisition  time  varies  from  2  to  4 
minutes/bed  position  depending  on  the  correction 
method used (segmented versus measured) [26-27]. 
The  use  of  CT  transmission  maps  for  attenuation 
correction reduces transmission acquisition time to 1-2 
minutes, including SCOUT and whole body CT scans, 
together  with  increased  accuracy  of  attenuation 
coefficients. 
Because  of  the  different  energy  of  CT  photons 
compared  with  the  emission  photons  (about  80  KeV 
versus 511 KeV) all commercial systems have a scaling 
algorithm to convert the correction factors from CT to 
PET [28-29]. 
All photon attenuation information embedded in the 
CT data is translated into the PET images because of the 
attenuation  correction.  For  this  reason  most  of  the 
PET/CT artefacts are related to the CT images and need 
to be accurately identified to avoid false positive reports. 
IMAGE ARTEFACTS 
PET/CT  image  artefacts  are  due  primarily  to 
metallic  implants,  respiratory  motion,  use  of  contrast 
media  and  image  truncation.  All  these  artefacts  are 
visible in both CT alone and in CTAC PET images. The 
artefacts do not appear in uncorrected PET images, so 
they may be used as control images for testing doubtful 
findings. 
Metallic implants 
The  presence  of  metallic  implants,  such  as  dental 
clogging,  dental  implants,  metallic  clips  and 
chemotherapy infusion ports, is visualised by CT images 
as areas of high density, which cause artefacts on the CT 
images [30-31]. These high CT numbers correspond to 
high  attenuation  coefficients  that  result  in  an 
overcorrection  of  the  PET  images,  promoting  false-
positive findings. The uncorrected images can help the 
nuclear  medicine  physician  to  identify  these  “hot” 
findings as artefacts.  
Figure 2 shows a typical artefact due to the presence 
of a metallic clip; it is very clear the effect of the higher 
CT  correction  on  the  PET  images  producing  a  false-
positive finding. A similar artefact can be caused by the 
presence of a pace maker (Figure 3). 
If the metallic implant size is sufficiently large (for 
example, a hip implant), the PET images do not present 
an artefact because the implant area is characterised by 
the  absence  of  activity  in  the  prosthetics.  Therefore, 
though the CT-derived attenuation coefficients are high, 
the corrected and uncorrected images are similar and are 
visualised as “cold” regions [32-34]. 
To  minimise  the  presence  of  artefacts  due  to 
metallic implants, the technologist should ask the patient 
to remove before scanning all metallic objects, such as 
coins,  jewels,  metallic  buttons,  belt  buckles,  bra  with 
iron inserts. Physicians should highlight in the anamnesis 
the presence of non-removable metallic implants.  
CT contrast media 
To  better  visualise  vessels  and  soft  tissues  and  to 
improve CT image quality, intravenous or oral contrast 
media are often administered to patients. However, the 
use  of  these  agents  can  introduce  changes  into  CT 
numbers  similar  to  metallic  implants,  affecting  the 
quantitative  and  qualitative  accuracy  of  CTAC  PET 
images  [35-41].  The  effect  of  contrast  media  artefacts 
increases  with  the  concentration  of  the  administered 
agent and depends on its clearance from patient’s body 
and the time between administration and CT acquisition. 
In  particular,  the  tissue  concentration  of  oral  contrast 
agents increases over time, so while their use during a 
PET/CT protocol gives all the benefits related to a better 
visualization of CT images without a real compromising 
of  CTAC  PET  images,  particular  attention  should  be 
taken if the patients had undergone a diagnostic CT scan 
with contrast few hours before the PET/CT scan.  
Several  correction  techniques  are  presented  in  the 
literature [42]. Nehmeh et al. [43] propose an interesting 
method to correct for CTAC PET images. This method is 
performed by contouring the contrast regions, excluding 
any  body  structures;  transforming  the  corresponding 
linear  attenuation  coefficients,  µ(x,  E),  of  contrast 
correctly  from  CT  to  PET  energies;  and,  finally, 
reconstructing CTAC PET images with the appropriately 
scaled attenuation map. 
Respiratory motion 
One of the most significant and frequent artefact in 
PET/CT  images  is  due  to  respiratory  motion  during 
scanning.  Although  the  use  of  a  combined  PET/CT 
scanner allows the registration of the two datasets in the 
simplest way, respiratory motion results into mismatch 
between  CT  and  corresponding  PET  slices  [44-46]. 
Because of the long acquisition time of the PET scan, the 
patient is allowed to breath normally during both CT and 
PET acquisitions. Asking the patient to hold the breath 
during the CT scan, as it’s normally done in diagnostic 
CT studies, can lead to artefacts because of the certain 
mismatch between a specific stage of the breath cycle 
during the CT and the average of many breathing cycles 
of  the  PET  images.  However,  even  if  the  patient  is 
usually  allowed  to  breathe  normally  during  the  whole 
PET/CT study, because of the fast CT, the diaphragm is 
visualised in a single position that is different from the 
mean  position  of  PET  images  or  in  the  course  of 
respiratory motion. 
As  described  by  Papathanassiou  et  al.  [47],  this 
phenomenon  not  only  sometimes  provokes 
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Figure 3  Focal artefact on CTAC PET images due to the presence of a pace maker. 
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misregistration  of  lesions  between  the  two  modalities 
(Figure 4) or disrupts image fusion of normal organs, but 
also  may  cause  an  erroneous  attenuation  correction. 
Because of respiratory motion the density of a particular 
organ  could  be  attributed  to  an  area  whose  density  is 
different. 
For  example,  the  downward  displacement  of  the 
diaphragm causes an underestimation of correction of the 
liver  dome,  leading  to  a  cold  area  in  that  zone.  It  is 
obvious that particular attention is needed if the patient is 
suspected for liver metastasis or for nodules at the base 
of the lung.  
The  best  way  to  correct  for  respiratory  motion 
would  be  to  acquire  gated  images  to  discriminate 
different intervals of a breath cycle. Many companies are 
working  to  implement  hardware  respiratory-motion 
correction  on  their  systems,  but  none  are  currently 
completely validated.  
Truncation 
The typical transverse field of view (FOV) of the 
CT scanner in a PET/CT system is about 50 cm, while 
the PET FOV is 70 cm. The relative small CT FOV can 
cause truncation of CT images [48]. To avoid truncation 
artefacts  in  PET/CT  images  patients  are  scanned  with 
arms above their head. However, in obese patients and in 
scans acquired with arms down, as with some patients 
with melanoma or head and neck tumours, this kind of 
artefact is frequently seen.  
As described by Mawlawi et al. [49] the aspect of 
truncation artefact in CT images is a bright rim of high 
attenuation values together with characteristic streaking, 
reflecting  on  PET-corrected  images  as  absence  of 
attenuation correction factors in the sections of the PET 
slices which exceed the CT FOV. The resultant artefact 
on  the  attenuation  corrected  PET  images  is  an 
overestimation  of  the  activity  concentration 
corresponding  to  the  rim  and  an  underestimation 
corresponding to the region without attenuation factors. 
Several  techniques  have  been  proposed  and 
implemented  on  commercial  systems  to  correct  for 
truncation artefacts and most of them give a recovery of 
more than 90% of the activity in the truncated regions. 
Hsieh et al [50] developed an algorithm for truncation 
correction  which  extends  the  CT  FOV  based  on 
information obtained from untruncated projections of the 
object and the knowledge that the total attenuation of an 
object should be the same independent of the projection 
angle. This technique has been implemented in the GE 
Discovery ST PET/CT system. 
Although the different techniques are effective for 
normal size patients, images of large or obese patients 
 
Figure 4  Misregistration of CT and PET malignant nodule of the right lung due to respiratory movement. 
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need a deeper analysis and in all cases corrected SUV 
measurements must be used carefully. 
CONCLUSION 
PET/CT  improves  quality  accuracy  of  the  image. 
The use of CT for attenuation correction yields several 
advantages in terms of accuracy and patient comfort. 
Several  artefacts  are  introduced  in  CTAC  PET 
images due to CT, but their knowledge and the use of 
proper  correction  techniques,  such  as  dedicated 
algorithms, which take into account the presence of high 
density materials, minimises any source of false findings. 
To avoid possible pitfalls, the simultaneous display 
of both CTAC and non-corrected PET images, side by 
side with CT images is strongly recommended. 
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